XML 25 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings Per Share
 6 Months Ended
Dec. 31, 2018
Earnings Per Share [Abstract]  
Earnings Per Share
EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted net (loss) earnings per share:
 
Three Months Ended December 31,
 
Six Months Ended December 31,
 
2018

2017
 
2018
 
2017
Numerator:
 
 
 
 
 
 
 
Net (loss) income from continuing operations
$
(29,278
)
 
$
43,130

 
$
(52,379
)
 
$
61,743

Net (loss) income from discontinued operations, net of tax
(37,223
)
 
3,973

 
(51,547
)
 
5,206

Net (loss) income
$
(66,501
)
 
$
47,103

 
$
(103,926
)
 
$
66,949

 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
Basic weighted average shares outstanding
104,056

 
103,837

 
104,009

 
103,773

Effect of dilutive stock options, unvested restricted stock and unvested restricted share units
—

 
603

 
—

 
606

Diluted weighted average shares outstanding
104,056

 
104,440

 
104,009

 
104,379

 
 
 
 
 
 
 
 
Basic net (loss) income per common share:
 
 
 
 
 
 
 
Continuing operations
$
(0.28
)
 
$
0.42

 
$
(0.50
)
 
$
0.59

Discontinued operations
(0.36
)
 
0.04

 
(0.50
)
 
0.05

Basic net (loss) income per common share
$
(0.64
)
 
$
0.45

 
$
(1.00
)
 
$
0.65

 
 
 
 
 
 
 
 
Diluted net (loss) income per common share:
 
 
 
 
 
 
 
Continuing operations
$
(0.28
)
 
$
0.41

 
$
(0.50
)
 
$
0.59

Discontinued operations
(0.36
)
 
0.04

 
(0.50
)
 
0.05

Diluted net (loss) income per common share
$
(0.64
)
 
$
0.45

 
$
(1.00
)
 
$
0.64



Basic net (loss) income per share excludes the dilutive effects of stock options, unvested restricted stock and unvested restricted share units. Due to our net loss in three and six months ended December 31, 2018, all common stock equivalents such as stock options and unvested restricted stock awards have been excluded from the computation of diluted net loss per share because the effect would have been anti-dilutive to the computations.  Diluted earnings per share in the three and six months ended December 31, 2017 includes the dilutive effects of common stock equivalents such as stock options and unvested restricted stock awards.
 
There were 1,152 and 567 stock-based awards excluded from our diluted earnings per share calculations for the three and six months ended December 31, 2018 and 2017, respectively, as such awards were contingently issuable based on market or performance conditions, and such conditions had not been achieved during the respective periods.

There were 388 restricted stock awards excluded from our diluted loss per share calculation for the three and six months ended December 31, 2018 as such awards were anti-dilutive. Anti-dilutive restricted stock awards excluded from our diluted earnings per share calculation for the three and six months ended December 31, 2017 were de minimis.

There were 111 potential shares of common stock issuable upon exercise of stock options excluded from diluted loss per share computations for the three and six months ended December 31, 2018, as they were anti-dilutive. No such awards were excluded for the three and six months ended December 31, 2017.

Share Repurchase Program

On June 21, 2017, the Company's Board of Directors authorized the repurchase of up to $250,000 of the Company’s issued and outstanding common stock. Repurchases may be made from time to time in the open market, pursuant to pre-set trading plans, in private transactions or otherwise. The authorization does not have a stated expiration date. The extent to which the Company repurchases its shares and the timing of such repurchases will depend upon market conditions and other corporate considerations, including the Company’s historical strategy of pursuing accretive acquisitions. As of December 31, 2018, the Company had not repurchased any shares under this program and had $250,000 of remaining capacity under the share repurchase program.